Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have different hormone levels than those without it.

A 15-year-old girl with no menstrual period was diagnosed with a genetic condition that makes her body unable to respond to male hormones, leading to female characteristics despite having male genetic makeup.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

Six months of treatment improved PCOS symptoms and reduced AMH levels.

Conditions affecting sex development show that sexual diversity is a natural part of human variation.

Cyproterone acetate and ethinylestradiol significantly lowered AMH levels in PCOS patients resistant to clomiphene.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Laparoscopic ovarian drilling helps infertile women with PCOS by improving menstrual regularity, ovulation, and chances of conception, and by changing hormone levels.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

Hormone levels studied are not linked to PCOS.

Vietnamese women with PCOS tend to be younger, have larger waists, higher AMH levels, and more body hair than those without PCOS.

Understanding genes and hormones is crucial for managing male puberty and sex development disorders.

The AMHR2-482A>G gene change is linked to higher PCOS risk.

Inositol was more effective than Metformin in treating symptoms of PCOS in women.

Inositol was more effective than metformin in improving menstrual cycles and pregnancy rates in PCOS patients.

Androgens regulate Sertoli cells and affect fertility through specific receptors and coregulators.

A new genetic mutation causes severe Leydig cell hypoplasia, affecting sexual development.

Weight loss can lower AMH levels in overweight and obese women with PCOS.

A model using hormone levels, cycle length, and BMI can help identify PCOS in Chinese women but isn't for screening teens.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

FAI is a reliable marker for identifying and monitoring hyperandrogenism in obese adolescent females with PCOS.

Platelet-rich plasma shows promise for treating various female reproductive health issues but requires more research.

Screening for reproductive health issues like endometriosis, PCOS, and STDs is crucial for early detection and prevention.

Diagnosing PCOS is challenging due to its complex and varied symptoms.

A short male anogenital distance may indicate incomplete masculinization due to disrupted androgen action.

DHT is crucial for urethral formation, and its disruption can affect masculinization and lead to hypospadias.

Insufficient androgen action in male fetuses can cause genital development issues due to genetic mutations or environmental chemicals.

Individuals with this condition often develop male traits and identities at puberty despite being raised as females.

Affected males are born with ambiguous genitalia, raised as females, but develop male traits at puberty due to enzyme deficiency.

Masculinization in affected individuals occurs gradually after puberty due to hormone changes.